Cargando…
Discovery of Potent Glucokinase and PPARγ Dual-Target Agonists through an Innovative Scheme for Regioselective Modification of Silybin
[Image: see text] Glucokinase (GK) and PPARγ are important targets for antidiabetic use. Silybin is one of the major active ingredients of Silybum marianum. The regioselective modification of the five hydroxyl groups in the silybin structure has always been a challenge. In this study, we found that...
Autores principales: | Zhang, Zhipeng, Meng, Yanqiu, Wang, Zhan, Mei, Yu, Gao, Shite, Wu, Yuejiao, Du, Shuxian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811767/ https://www.ncbi.nlm.nih.gov/pubmed/35128289 http://dx.doi.org/10.1021/acsomega.1c06778 |
Ejemplares similares
-
Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015) -
Discovery and
Structure-Based Design of Potent Covalent
PPARγ Inverse-Agonists BAY-4931 and BAY-0069
por: Orsi, Douglas L., et al.
Publicado: (2022) -
Correction
to “Discovery and Structure-Based
Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and
BAY-0069”
por: Orsi, Douglas L., et al.
Publicado: (2022) -
PPARγ Agonists: Blood Pressure and Edema
por: Blazer-Yost, Bonnie L.
Publicado: (2010) -
PPARγ Agonists: Emergent Therapy in Endometriosis
por: Vallée, Alexandre, et al.
Publicado: (2021)